Amsterdam Umc Venture HoldingUtrecht Health Seed Fund (Uhsf)Dutch Research Council (Nwo)Hubrecht InstituteFirst FundROM Utrecht Region
Description
Naarden-based Phlox Therapeutics has raised €1.9M in funding to advance its RNA therapies for genetic laminopathies. The funding round includes ROM Utrecht Region and other existing investors, with additional non-dilutive investment from the Dutch Research Council.
Who to call at Phlox Therapeutics, and when
A new round usually means Phlox Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Phlox Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Phlox Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Phlox Therapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Phlox Therapeutics
Location
Naarden, North Holland, Netherlands
About
Phlox Therapeutics is a biotechnology company founded in 2022 that specializes in developing RNA-based gene therapies to treat genetic laminopathies and cardiomyopathies. The company focuses on targeting genetic mutations associated with these conditions, aiming to improve patient outcomes. By advancing its RNA technology, Phlox aims to become a key player in next-generation RNA therapies for genetic heart diseases. Their work seeks to address currently untreatable genetic conditions and improve treatment options for patients.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Phlox Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.